Economic and Outcome Studies Flashcards

0
Q

Examples of patient outcomes:

A
Economic 
Clinical
 humanistic 
Outcomes 
(ECHO)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Definition of outcomes research

A

Attempt to identify, measure, as evaluate end result of health care services. Compares competing options in routine care settings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Example of humanistic outcomes

A

Health related quality of life

Satisfaction with health care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pharmacoecomonic studies

A

Includes economic and clinical/humanistic outcome evals and comparisons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Efficacy vs effectiveness

A

Efficacy : randomize controlled trials

Effectiveness: outcomes studies

Efficacy advantages:
Needed for FDA approval, higher internal validity (more sure of cause and effect, less confounding)
Less chance for baseline diff
Higher pt adherence (real or artificial?)

Effectiveness data advantage

  • higher external validity (generalize able)
  • broader range of pts
  • can follow for longer time frame
  • larger sample size
  • pharmacoeconomic studies included
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Statistic and value suggesting heterogeneity may be a problem

A

I-squared value of 50% or more

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cost minimization analysis

A

Assume benefits to be equivalent so lowest cost in $ best

Advantage: simple, no outcomes measures needed
Disadvantage:
- most things have different outcomes so not many uses in real life
- strength depends on strength of evidence that tx equivalent- FDA vs RCT vs “expert opinion”
consequences not measured so some say not true pharmacoeconomic study

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cost effectiveness analysis

A

Measure in Natural units eg life years gained , mm Hg, mmol/L glucose, PANNS score

Advantage: clinician familiar with measuring clinical outcomes
FDA has standards for clinical outcome measurement
Do not have to place dollar value on clinical outcomes

Disadvantage: can only compare options with same type of clinical outcome
Only one clinical outcome at a time can be measured
Metal health outcomes hard to measure

Cost effectiveness grid see p 255

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cost benefit analysis

A

Cost - $
Outcome - Also converted to $ so better outcomes can be associated with higher outcome $$ even if there are higher $$ costs initially
- input and output are $ units - if benefit: cost >1 => cost beneficial

Advantage: can compare tx with different outcomes , and can determine if added benefits outweigh costs

Disadvantage: difficult to put $$ on outcomes, and disagreement on how to value these outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cost utility analysis

A

QALY
COst utility analysis is cost per outcome of QALY
- some view it as a subset of CEA
Advantage: includes pt preferences
Single measure to incorporate morbidity and mortality
Allows comparisons across different options
Disadvantage: time consuming, results vary and depends on quality measure and instrument

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Perspective on costs

A

Payer - insurance co
Provider - hospital or clinic or possibly ACA
Society - includes non medical costs eg homeless shelters, reduced productivity etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Types of costs

A

Direct medical
Direct non medical
Indirect costs
Tangible costs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Direct non-medical costs

Examples and definitions

A

Law enforcement
Shelters
Jails
Subsidies for housing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Indirect costs

Examples and definition

A
Unemployment
Reduced productivity at work
Premature mortality eg suicide
Caregiver reduced productivity
Level of employment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Decision analysis

A
  • systematic quantitative approach for assessing relative value of one or more decision options
  • usually depicted by a graph caled a decision tree
    Steps of decision :
    1) identity specific decision - from whose perspective, define options, one what time period
    2) draw decision structure structure over time: boxes are choice nodes (drug a vs drug b), circles represent chance nodes (ADR or no ADR etc)
    Triangles are termination nodes (death, exit plan etc)
    3) assess probabilities
    • use past literature, experts judges etc
    • use reasonable ranges for uncertain prob (see sensitivity analysis)
    • 4) determine value of each outcome - must be same for each option eg QALY vs QALY or success rate vs success rate
      5) conduct sensitivity analysis
    • choose values or probabilities most uncertain or where small difference has a big impact
      Use reasonable ranges. Recalculate using the ranges and determine the degree of sensitivity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

If results of a PE analysis change based on different assumptions - sensitivity analysis - is the result considered sensitive or insensitive?

A

If results don’t change - insensitive - more robust/ reliable

If results change based on sensitivity analysis - more sensitive - use much more caution in applying and interpreting results

16
Q

One way sensitivity analysis

A

Only changes assumptions of one variable at a time while holding the others constant

17
Q

Systematic review vs meta analysis

Hint: many systematic reviews use meta analysis

A

Systematic review: collate empirical evidence with pre-specified eligibility criteria to answer a specific research question

Meta analysis: statistical technique to combine results of previous studies to estimate effect size when smaller studies are pooled. Larger studies weigh more heavily into outcomes than smaller ones

18
Q

Meta analysis transparency tools

A

QUOROM

PRISMA

19
Q

Steps in meta analysis

A

1) identify studies
- medline emabse etc
2) define eligibility
- specific and objective
3) extract info
- collect data needed
- use second reviewer for all these steps
4) analyze statistically
- see example p 263-3

20
Q

Test for heterogeneity

A

Overall result should depend in the intervention and not other variables - use stats to determine if type of funding, type of participants, dose, etc)
- variance higher than that applicable to chance alone = heterogeneity
- two terms:
Cochran Q
I squared - inconsistency measure - measures the variation percent due to heterogeneity rather than chance - >50% implies may be too much heterogeneity

21
Q

Test for publication bias

A

Funnel plot
Compares the effect (function of risk ratio or risk difference) by precision (sample size or standard error)
- pub bias-> small studies may show larger estimates of effect size
If plot asymmetrical - pub bias may exist - see p 267
- controversy over using this - may be other reasons than pub bias that smaller studies have more effect - different pt Populations, different dose, etc